Eli Lilly, the drugmaker with two weight-loss bestsellers, just got its first dose of healthy skeptism during a time when the ...

The companies announced a long-term collaboration to make obesity treatments more affordable, they said on Tuesday.

Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

Novo Nordisk A/S is partnering with telehealth companies including Hims & Hers Health Inc., LifeMD Inc., and Ro to offer ...

We recently published a list of the 10 Best Long-Term Dividend Stocks to Buy According to Billionaires. In this article, we ...

Hims & Hers ( HIMS) stock popped more than 20% in trading early Tuesday after Novo Nordisk ( NVO) announced a partnership with it and other telehealth platforms to offer patients access to the ...

The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...

In a joint venture with Novo Nordisk, Hims & Hers will dispense all doses of Wegovy to Americans who buy eligible subscriptions, with plans starting at $599 a month. The offering ...

The stock (HIMS) soared 24.2% in midday trading toward a one-month closing high. It's on track the biggest one-day gain since it ran up 27.7% on Feb. 13, 2025. That rally was part of a big surge to ...